Supply Chain

Why ‘real-time-all-the-time’ supply chain operations are fundamental to biopharma success

The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic

The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US

A recommended checklist for manufacturers as they enlist distributor and 3PL support—and the important questions they should be asking themselves

Pressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance

Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials

The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges

What makes a third-party logistics provider independent?

Drugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain

Having recently led the launch of LogiCare3PL, Omar Agado of BioCare talks about what’s next for the growing third-party logistics space

Goal of ‘Closer to the Formulator’ is to offer a more efficient pharma production process

Deal establishes company’s presence in Mexico

Location will feature aseptic fill-finish technology

Per supply chain agreement, CDMO will provide analytical product support

Facility will feature biologic manufacturing, along with late-stage research and clinical development of cancer medicines

Decrease influenced by various worldwide economic developments, IATA says

Graham Cromb, Vice President of Europe Operations at UPS Healthcare talks about how the COVID-19 pandemic fueled UPS’ expansion in Europe, and where the company is heading in the post-COVID landscape

Series of documents promotes best practices for managing and measuring data quality

From November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now

Acquisition works toward addressing needs of regenerative medicine industry

Includes a 36,000-square-foot addition to Charlottetown location

Includes 100,000 square feet of controlled ambient storage

Campus will feature a CDMO, over 1,000,000 square feet of floor space

Global demand for the aforementioned month was greater than 2021, report shows

Company strives to provide essential medicines that are in low supply